Nuo Therapeutics
Gaithersburg
About Nuo Therapeutics
Nuo Therapeutics is a biotechnology company that develops, sells, and licenses regenerative biological therapies to primarily address the areas of wound care, inflammation, and angiogenesis. The Company markets the AutoloGel System, a device for the production of platelet rich plasma gel derived from the patient's own blood. The AutoloGel System is cleared by the United States Food and Drug Administration for use on a variety of exuding wounds. Nuo Therapeutics is headquartered in Gaithersburg, Maryland.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $120.6M
- Funding stage: IPO
- Last round: Post-IPO Equity (Aug 2025)
- Ticker: otcbb:NUOT
- Website: nuot.com
- Phone: +118662986633
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/nuo-therapeutics-164784 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.